Improving quality of life and outcomes for cancer patients, through the first noninvasive white blood cell monitoring device. Spun out from
@MIT
@La_UPM
@MIT
@La_UPM
Location: United States, Massachusetts, Boston
Employees: 1-10
Total raised: $16.3M
Investors 5
Date | Name | Website |
- | Health Tec... | hthvc.com |
27.07.2022 | MassVentur... | mass-ventu... |
- | Blue Goose... | bluegoosec... |
08.03.2022 | Dorm Room ... | dormroomfu... |
10.03.2022 | Good Growt... | goodgrowth... |
Funding Rounds 4
Date | Series | Amount | Investors |
26.07.2024 | Grant | $4.5M | - |
23.09.2022 | Series A | $5M | - |
23.09.2022 | Series A | $5M | IAG Capita... |
23.07.2019 | Seed | $1.8M | - |
Mentions in press and media 5
Date | Title | Description |
26.07.2024 | Leuko: Non-Invasive Blood Testing MIT Spinout Receives $4.5 Million NIH Grant | Leuko, a medical tech company pioneering the field of non-invasive blood testing, announced that it has received a $4.5 million SBIR Phase IIB award from the National Institutes of Health (NIH) National Cancer Institute (NCI) for the contin... |
11.10.2022 | Leuko closes €5M Series A round | EIT Health-supported start-up Leuko has closed a Series A funding of €5 million. The new funding will be used to accelerate clinical trials to obtain regulatory approval in collaboration with leading cancer centres, including Boston Medical... |
23.09.2022 | Leuko Raises $5M in Series A Funding | Leuko, an MIT startup developing a solution that enables at-home noninvasive white blood cell (WBC) monitoring, announced a first closing of $5m for their Series A round. The new funding came HTH VC, Good Growth Capital, IAG Capital Partner... |
27.05.2022 | EIT Health Catapult 2021-22 names winners | This year’s EIT Health Catapult competition crowned Ebenbuild, Leuko and SolasCure as champions at the EIT Health Summit. The Catapult competition looks to boost the development of European health start-ups by exposing them to world-class e... |
06.12.2021 | 21 start-ups reach EIT Health Catapult Final | Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final. The finalists represent the most promising European start-ups across biotech, medtech and digital health. The EIT Health Catapult, currentl... |